CN117425652A - 新盐和晶体 - Google Patents
新盐和晶体 Download PDFInfo
- Publication number
- CN117425652A CN117425652A CN202280040536.9A CN202280040536A CN117425652A CN 117425652 A CN117425652 A CN 117425652A CN 202280040536 A CN202280040536 A CN 202280040536A CN 117425652 A CN117425652 A CN 117425652A
- Authority
- CN
- China
- Prior art keywords
- salt
- less
- acid
- disorder
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163197848P | 2021-06-07 | 2021-06-07 | |
| US63/197,848 | 2021-06-07 | ||
| PCT/US2022/072802 WO2022261633A1 (en) | 2021-06-07 | 2022-06-07 | Novel salts and crystals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117425652A true CN117425652A (zh) | 2024-01-19 |
Family
ID=84425422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280040536.9A Pending CN117425652A (zh) | 2021-06-07 | 2022-06-07 | 新盐和晶体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240279228A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4352057A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024520751A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240018528A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117425652A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022289909A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3217549A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308750A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014398A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022261633A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2743513C2 (ru) | 2016-01-26 | 2021-02-19 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| WO2019067591A1 (en) | 2017-09-26 | 2019-04-04 | Intra-Cellular Therapies, Inc. | NEW SALTS AND CRYSTALS |
| IL315005B2 (en) | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| ES3047409T3 (en) | 2018-12-17 | 2025-12-03 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| US12331052B2 (en) | 2018-12-21 | 2025-06-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2530090T3 (es) * | 2008-03-12 | 2015-02-26 | Intra-Cellular Therapies, Inc. | Sólido de gamma-carbolinas fusionadas con heterociclo sustituido |
| RU2743513C2 (ru) * | 2016-01-26 | 2021-02-19 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| WO2017172811A1 (en) * | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
| EP3801527B1 (en) * | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| IL315005B2 (en) * | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| JP7377871B2 (ja) * | 2018-12-21 | 2023-11-10 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
-
2022
- 2022-06-07 IL IL308750A patent/IL308750A/en unknown
- 2022-06-07 MX MX2023014398A patent/MX2023014398A/es unknown
- 2022-06-07 KR KR1020237045333A patent/KR20240018528A/ko active Pending
- 2022-06-07 WO PCT/US2022/072802 patent/WO2022261633A1/en not_active Ceased
- 2022-06-07 US US18/567,743 patent/US20240279228A1/en active Pending
- 2022-06-07 CA CA3217549A patent/CA3217549A1/en active Pending
- 2022-06-07 EP EP22821240.3A patent/EP4352057A4/en active Pending
- 2022-06-07 JP JP2023575364A patent/JP2024520751A/ja active Pending
- 2022-06-07 CN CN202280040536.9A patent/CN117425652A/zh active Pending
- 2022-06-07 AU AU2022289909A patent/AU2022289909A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL308750A (en) | 2024-01-01 |
| WO2022261633A1 (en) | 2022-12-15 |
| US20240279228A1 (en) | 2024-08-22 |
| EP4352057A4 (en) | 2025-04-16 |
| KR20240018528A (ko) | 2024-02-13 |
| AU2022289909A1 (en) | 2023-11-16 |
| AU2022289909A2 (en) | 2024-01-18 |
| MX2023014398A (es) | 2023-12-15 |
| CA3217549A1 (en) | 2022-12-15 |
| EP4352057A1 (en) | 2024-04-17 |
| JP2024520751A (ja) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240279228A1 (en) | Novel salts and crystals | |
| WO2020053660A1 (en) | Solid forms of a bet inhibitor | |
| TWI882617B (zh) | 3-((1r,3r)-1-(2,6-二氟-4-((1-(3-氟丙基)氮雜環丁-3-基)胺基)苯基)-3-甲基-1,3,4,9-四氫-2h-吡啶并[3,4-b]吲哚-2-基)-2,2-二氟丙-1-醇之固體形式及用於製備包含經取代苯基或吡啶基部分之稠合三環化合物之製程,包括其使用方法 | |
| KR102845326B1 (ko) | Gabaa 양성 알로스테릭 조절인자의 염 및 결정 형태 | |
| CN102112465B (zh) | 6-[(4s)-2-甲基-4-(2-萘基)-1,2,3,4-四氢异喹啉-7-基]哒嗪-3-胺的晶型 | |
| CN113227045B (zh) | 取代的杂环稠合的γ-咔啉的合成 | |
| AU2019280850A1 (en) | Novel salts and crystals | |
| KR20180030964A (ko) | 이브루티닙과 카복실산의 공결정체 | |
| KR20110135397A (ko) | 시타글립틴 염의 고체 상태 형태 | |
| JP2014521726A5 (cg-RX-API-DMAC7.html) | ||
| WO2014093583A2 (en) | Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof | |
| TW201546045A (zh) | 新穎結晶性芳烷基胺化合物及其製造方法 | |
| TW201718516A (zh) | 組蛋白去乙醯酶抑制劑之晶形 | |
| CN111617083A (zh) | 甲氧基取代苯基酰胺类氨基嘧啶衍生物的应用 | |
| EP3357907B1 (en) | Maleic acid salt of a silodosin intermediate | |
| IL291221B1 (en) | Methods for the synthesis of wolbenzen | |
| CN111620854A (zh) | 4-氨基嘧啶取代的苯基酰胺类化合物及其制备方法 | |
| HK40105339A (en) | Novel salts and crystals | |
| TW202306954A (zh) | Ripk1抑制劑的晶型及其酸式鹽和其酸式鹽的晶型 | |
| CN118812542A (zh) | 2-吲哚啉螺环酮类化合物或其盐、溶剂合物的无定形形式或结晶形式 | |
| WO2025209524A1 (en) | Crystalline tead inhibitor and uses thereof | |
| WO2025231053A1 (en) | Solid forms of 6-chloro-3-[(1r)-1-[3,6-dimethyl-2-(2-methylindazol-5-yl)-4-oxo-chromen-8-yl]ethoxy]pyridine-2-carboxamide | |
| WO2024236024A1 (en) | Preparation of (s)-6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide in enantiomerically enriched form by resolution process | |
| CN121627586A (zh) | 一种新型苄基异喹啉类化合物、其药物组合物及其应用 | |
| CN117624138A (zh) | 一种氧杂螺环类衍生物的可药用盐、晶型及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40105339 Country of ref document: HK |